EQS-News: Formycon AG / Key word(s): Market LaunchFormycon announces commercial launch of FYB201 (Ranibizumab) in Canada (RanoptoTM) and Switzerland (Ranivisio®) 11.04.2024 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press release // April 11, 2024 Formycon announces co.
EQS-News: Formycon AG / Key word: Market Launch
Formycon announces commercial launch of FYB201 in Canada and Switzerland
11.04.2024 / 07:30 CET/CEST
The issuer is.
A young Ontario man who used his creative talents and the power of social media to advocate for the blind community is now recovering after being among the first in his province to receive a rare and expensive gene therapy to help his vision loss.
A young Pickering man who has amassed a big social media following for his advocacy for blind people is set to receive a sight-saving gene therapy the first time in Ontario the immensely expensive procedure will be covered by OHIP.